Contact

Contact

An independent resource on ibogaine for people researching ibogaine.

If you have corrections, questions, or feedback about the site’s content or sources, we welcome brief messages sent through our published channels. For information on how Is Ibogaine Dangerous gathers and verifies material, see our about page for an explanation of editorial approach and sourcing practices; that page also describes how we handle corrections and updates to content found on the site — visit our editorial approach and sourcing page for details.

Currently, contact details are not listed publicly. Please check back here for a published contact method; until then the site can be reached through its published channels and the listed editorial pathways. You can also review how the medication is administered in practical settings via an external guide on administration practices at detailed administration practices.

Returning to the start of our content collection can help if you're exploring other resources; a quick way to find the main hub is in the site header or by following this link back to the main resource hub at the site’s main page.

Close-up detail image accompanying contact information and resource hub

How to reach Is Ibogaine Dangerous

We are a newly launched independent information resource focused on evidence, safety, legality and practical questions about ibogaine.

At present this page does not publish a direct email or phone contact. If and when a public contact method is established we will post it here and describe the preferred channels for corrections and media inquiries. For now, readers who want to understand our editorial principles and how we vet sources should visit the about section for a concise description of our mission and sourcing — that material helps explain how to suggest a correction or submit source material: see the about page.

Corrections and feedback

We value precise information. If you believe an item on this site contains an error, the preferred route is through the site's published channels once they are posted; watch this page for updates. In the meantime, many readers use the site navigation to locate source notes and reach out to original publishers directly for verification — for example, clinical protocols and administration notes are discussed across specialist sources such as established pharmacology references and clinical databases.

Privacy and response

When a contact method is published we will include a short note on expected response times and privacy practices. Until then, please check back later for a posted mailto or other operator-configured contact endpoint.

Quick links

Browse core site sections using the header navigation; for editorial context about the site’s approach to evidence and safety see the about page’s overview of sourcing, and for a concise listing of our services and offerings for researchers visit services and resources.